rs35742686
Positions:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BS1BS2
The NM_000106.6(CYP2D6):βc.775delAβ(p.Arg259fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0152 in 1,610,668 control chromosomes in the GnomAD database, including 957 homozygotes. Variant has been reported in ClinVar as Likely benign,other (β β ). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: π 0.012 ( 63 hom., cov: 31)
Exomes π: 0.015 ( 894 hom. )
Consequence
CYP2D6
NM_000106.6 frameshift
NM_000106.6 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.218
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0123 (1854/151158) while in subpopulation NFE AF= 0.017 (1150/67728). AF 95% confidence interval is 0.0162. There are 63 homozygotes in gnomad4. There are 929 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 1854 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0123 AC: 1854AN: 151044Hom.: 63 Cov.: 31
GnomAD3 genomes
AF:
AC:
1854
AN:
151044
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0122 AC: 3049AN: 249674Hom.: 100 AF XY: 0.0120 AC XY: 1626AN XY: 134986
GnomAD3 exomes
AF:
AC:
3049
AN:
249674
Hom.:
AF XY:
AC XY:
1626
AN XY:
134986
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0155 AC: 22551AN: 1459510Hom.: 894 Cov.: 34 AF XY: 0.0149 AC XY: 10840AN XY: 726018
GnomAD4 exome
AF:
AC:
22551
AN:
1459510
Hom.:
Cov.:
34
AF XY:
AC XY:
10840
AN XY:
726018
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0123 AC: 1854AN: 151158Hom.: 63 Cov.: 31 AF XY: 0.0126 AC XY: 929AN XY: 73878
GnomAD4 genome
AF:
AC:
1854
AN:
151158
Hom.:
Cov.:
31
AF XY:
AC XY:
929
AN XY:
73878
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
13
AN:
3466
ClinVar
Significance: Likely benign; other
Submissions summary: Benign:1Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1Other:1
other, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 06, 2018 | - Variant classified as "other reportable" ??? variant is clinically benign (not associated with disease) but is reported when observed (e.g. pseudodeficiency alleles). |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Apr 12, 2018 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Debrisoquine, poor metabolism of Other:1
drug response, no assertion criteria provided | literature only | OMIM | Jun 01, 1997 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at